Last reviewed · How we verify

NCT04815733

Pressure Support Ventilation During Laparoscopic and Abdominal Robotic Surgery.

Completed NA Last updated 26 April 2023
What this trial tests

NA trial testing Mandatory ventilation in Ventilator-Induced Lung Injury in 106 participants. Completed in 31 March 2023.

Timeline
1 June 2017
Primary endpoint
31 March 2023
31 March 2023

Quick facts

Lead sponsorMoscow Clinical Scientific Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment106
Start date1 June 2017
Primary completion31 March 2023
Estimated completion31 March 2023
Sites1 location across Russia

Drugs / interventions tested

Conditions studied

Sponsor

Moscow Clinical Scientific Center

Who can join

18 and older, any sex, with Ventilator-Induced Lung Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-center, blind, prospective, randomized, controlled trial of pressure support ventilation (PSVpro) versus pressure control ventilation - volume guaranteed (PCV - VG) during laparoscopic and robotic abdominal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Ventilator-Induced Lung Injury

Currently open trials in the same condition.

Other Moscow Clinical Scientific Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04815733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing